Physician profile
Paul C Walker
NPI 1609837053
$723.81
in general payments reported to CMS, 2019-2025
15 companies · $16.09 in 2025
The $16.09 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.12 · 2020: $65.63 · 2021: $322 · 2022: $230 · 2023: $25.47 · 2025: $16.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $100.02 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $76.44 | 2020-2022 | |
| Novo Nordisk INC | $76.19 | 2020-2022 | |
| Abbvie INC. | $64.74 | 2021-2023 | Ubrelvy |
| Amgen INC. | $61.95 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.52 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $48.81 | 2021-2022 | |
| Lilly USA, LLC | $46.85 | 2021 | |
| Exelixis INC. | $45.32 | 2019 | |
| Abbott Laboratories | $39.49 | 2021-2022 | |
| Pfizer INC. | $36.17 | 2021-2022 | |
| Esperion Therapeutics, INC. | $21.11 | 2020 | |
| Astellas Pharma US INC | $19.19 | 2021 | |
| Stryker Corporation | $16.09 | 2025 | Clottriever Bold Catheter |
| Glaxosmithkline, LLC. | $14.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.